First patients test new pill targeting leukemia
Disease control
Ongoing
This is the first study in people testing a new oral drug called BMF-500 for adults with acute myeloid leukemia (AML), a type of blood cancer. The main goals are to find a safe dose and see how the body handles the drug. The study will also look for early signs that the drug migh…
Phase: PHASE1 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC